2025
March
![]() Public Domain by Garrondo
| A new study finds that two drugs, lecanemab and donanemab, can add on average 10 and 13 additional months of independent living to patients with beginning Alzheimer's disease. related: #Alzheimer |
See also on Mastodon @neat_news.